YYAI vs PRCT vs ISRG vs BBAI

For growth investors, AiRWA Inc.

(YYAI) is the stronger pick with 52. 6% revenue growth year-over-year, versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). AiRWA Inc. (YYAI) offers the better valuation at 0. 1x trailing P/E, making it the more compelling value choice. Analysts rate PROCEPT BioRobotics Corporation (PRCT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, AiRWA Inc.

(YYAI) is the cheapest at 0. 1x versus Intuitive Surgical, Inc. at 57. 2x.

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +61. 7%, compared to -100. 0% for AiRWA Inc. (YYAI). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus YYAI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 00β versus BigBear. ai Holdings, Inc. 's 3. 31β — meaning BBAI is approximately 232% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 14% for PROCEPT BioRobotics Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), AiRWA Inc.

(YYAI) is pulling ahead at 52. 6% versus -19. 3% for BigBear. ai Holdings, Inc. (BBAI). On earnings-per-share growth, the picture is similar: AiRWA Inc. grew EPS 100. 8% year-over-year, compared to 1. 7% for PROCEPT BioRobotics Corporation. Over a 3-year CAGR, PRCT leads at 60. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -230. 2% for BigBear. ai Holdings, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: YYAI leads at 51. 3% versus -65. 3% for BBAI. At the gross margin level — before operating expenses — YYAI leads at 76. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for PRCT: 66.

9% to $42. 40.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +549. 2% 10Y return). AiRWA Inc. (YYAI) carries a higher beta of 3. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +549. 2%, YYAI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (YYAI (Consumer Cyclical) and PRCT (Healthcare) and ISRG (Healthcare) and BBAI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: YYAI is a small-cap high-growth stock; PRCT is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock; BBAI is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.